The short version of GLP-1 receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-25. Anything still debated is marked as such rather than presented as settled.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
As a peptide, the compound is generally supplied as a lyophilized powder and stored frozen to slow degradation. Recommended conditions usually sit at minus twenty degrees Celsius or colder, shielded from light and moisture. Solutions are less stable than the dry powder and are often prepared fresh before analysis. Repeated freeze-thaw cycles can drive aggregation, so splitting stock material into small aliquots reduces handling stress and preserves sample integrity.
Quality control of research material relies on several complementary checks. Purity testing confirms the absence of truncated or oxidized peptide species, while water content and counterion analysis show how much mass comes from salts rather than the peptide itself. Sequence verification through tandem mass spectrometry ensures the correct amino acid chain. Because unregulated suppliers vary widely, independent verification of identity and purity is often necessary before a sample enters experiments.
==== Impact of the Tokyo Code (1993) ==== The Tokyo Code of 1993 extended the provisions for conserving names to all species, not just those of major economic importance. This change in the International Code of Botanical Nomenclature allowed for the conservation of names that would promote nomenclatural stability. Despite this provision, no formal proposal was made to conserve the name Parmotrema chinense, and thus it did not gain widespread acceptance. David Hawksworth's 2004 study brought significant clarity to the taxonomic confusion. He rediscovered Osbeck's original material in Linnaeus' herbarium and identified it as belonging to Parmotrema tinctorum, not Parmotrema perlatum. Hawksworth demonstrated that Lichen chinensis was not validly published because it lacked a proper description and was linked with an expression of doubt by Osbeck. Hawksworth's work led to the reinstatement of the name Parmotrema perlatum, confirming that Hudson's name was legitimate and should continue to be used. This resolution was based on the original typification by Hale and the invalid publication status of Lichen chinensis. Recent studies suggest that the circumscription of Parmotrema perlatum may need to be revised. Research utilising DNA sequencing has uncovered cryptic diversity within the genus Parmotrema, indicating that traditional phenotype-based identification methods may underestimate species diversity. Specifically, the genetic analysis of P. perlatum and related species revealed multiple distinct lineages that were previously grouped under a single nominal taxon.
. The simulation first updates the infected from the susceptible and then the removed category is updated from the infected category for the next time point (t=1). This describes the flow persons between the three categories. During an epidemic the susceptible category is not shifted with this model,
Prior to a law change in 2006, babies of non-citizens born in New Zealand were entitled to New Zealand citizenship. 18 February: Government Statistician Mark Sowden confirms he will resign on 30 March after an inquiry by the Public Service Commission into data breach allegations at Manurewa Marae in 2023 criticised Statistics New Zealand's handling of personal information and management of conflicts of interest. Torrential rain leads to flash flooding in parts of Otago including Beaumont. 19 February: The New Zealand Government establishes a NZ$2 million dual purpose fund to honour children who died in care and were buried in unmarked graves. A group of abuse survivors picket the Accident Compensation Corporation's Christchurch office, demanding the company reform eligibility coverage policies for abuse survivors. 20 February: Associate Immigration Minister Chris Penk uses his discretionary powers to grant Davan Kumar a residency visa but upholds the deportation order against his overstayer parents. Australian and New Zealand Defence Ministers Richard Marles and Judith Collins confirm that the Australian and New Zealand Defence Forces are monitoring three Chinese warships that are sailing through international waters near Sydney. New Zealand Media and Entertainment confirms plans to layoff several senior reporters and create a new Free ad-supported streaming television (FAST) channel. 21 February: Flights between Australia and New Zealand are diverted after the Chinese Navy conducts live fire drills using warships 340 nautical miles east of Sydney, in international waters.
Sources: en.wikipedia.org
== See also == Methane Isotope Carbon isotopes Hydrogen isotopes Isotopic signature Isotope geochemistry Isotopologue Isotopomer Clumped isotopes Isotope-ratio mass spectrometry Hydrogen isotope geochemistry of natural gas Methanogenesis Kinetic isotope effect
=== Pharmacokinetics === Information about pharmacokinetics and pharmacodynamics of DNP in humans is limited. DNP is metabolized via nitro reduction. Its major metabolites are 2-amino-4-nitrophenol and 4-amino-2-nitrophenol. In overdoses, symptom onset can be as soon as 3 hours and the average time to death was 14 hours.
Daniel S. Greenspan is an American biomedical scientist, academic and researcher. He is Kellett professor of Cell and Regenerative Biology at the University of Wisconsin-Madison School of Medicine and Public Health. He has authored over 120 publications. His research has mainly focused on genes encoding proteins of the extracellular space and possible links between defects in such genes and human development and disease.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。